Thyroid status in patients with early stages of cancer of various localization
Purpose of the study. To determine the thyroid status of primary cancer patients in the early stages of uterine body cancer, kidney cancer, breast cancer, skin melanoma and lung cancer without a history of endocrine pathology.Patients and methods. The content levels of thyroid-stimulating hormone (T...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
QUASAR, LLC
2024-06-01
|
| Series: | Исследования и практика в медицине |
| Subjects: | |
| Online Access: | https://www.rpmj.ru/rpmj/article/view/988 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849241240218894336 |
|---|---|
| author | V. A. Bandovkina E. M. Frantsiyants A. M. Salatova M. A. Еngibaryan V. L. Volkova N. D. Cheryarina |
| author_facet | V. A. Bandovkina E. M. Frantsiyants A. M. Salatova M. A. Еngibaryan V. L. Volkova N. D. Cheryarina |
| author_sort | V. A. Bandovkina |
| collection | DOAJ |
| description | Purpose of the study. To determine the thyroid status of primary cancer patients in the early stages of uterine body cancer, kidney cancer, breast cancer, skin melanoma and lung cancer without a history of endocrine pathology.Patients and methods. The content levels of thyroid-stimulating hormone (TSH), thyroid hormones (THs) T4 and T3 of total and free forms were determined in the blood serum by RIA method in 132 patients with breast cancer, uterine body cancer, lung cancer, kidney cancer and skin melanoma (average age 55 years). The comparison group consisted of practically healthy donors.Results. Only in skin melanoma, serum TSH levels were reduced by 1.5 times (p < 0.05). The T4 content was reduced by 1.4–1.7 times (p < 0.05) in uterine body cancer and kidney cancer, increased in lung cancer patients and 16 % of breast cancer patients by 1.4–1.7 times though (p < 0.05). A 1.3–1.5‑fold low (p < 0.05) T3 level was found in breast cancer, kidney cancer, and skin melanoma, while an 1.6‑fold increase (p < 0.05) was found in uterine body cancer. The revealed changes in THs by the type of clinical hyperthyroidism are an increase of 1.8 times (p < 0.05) FT3 on the background of low TSH in the blood in patients with skin melanoma, and by the type of hyperthyroxinemia in patients with lung cancer and breast cancer, consisting in increased concentrations of T4 and FT3, and with free and total T3 levels in patients uterine body cancer, as well as FT4, without changes in TSH in the blood serum of patients, may be associated with the features of malignant pathology, since it is known that THs are proliferation stimulants and can build up in tumors.Conclusion. The development of a malignant tumor even in the early stages of the disease is perceived by the body as a threat for homeostasis and the response to the occurrence of neoplasm is the reaction of the hypothalamicpituitary-thyroid regulatory axis. As an outcome, patients develop euthyroid disorder syndrome. |
| format | Article |
| id | doaj-art-2d2251cf88614d8d8aaf2bc1b35a4eca |
| institution | Kabale University |
| issn | 2410-1893 |
| language | Russian |
| publishDate | 2024-06-01 |
| publisher | QUASAR, LLC |
| record_format | Article |
| series | Исследования и практика в медицине |
| spelling | doaj-art-2d2251cf88614d8d8aaf2bc1b35a4eca2025-08-20T04:00:14ZrusQUASAR, LLCИсследования и практика в медицине2410-18932024-06-01112465610.17709/2410-1893-2024-11-2-4538Thyroid status in patients with early stages of cancer of various localizationV. A. Bandovkina0E. M. Frantsiyants1A. M. Salatova2M. A. Еngibaryan3V. L. Volkova4N. D. Cheryarina5National Medical Research Centre for Oncology<p> Rostov-on-Don, Russian FederationNational Medical Research Centre for Oncology<p> Rostov-on-Don, Russian FederationNational Medical Research Centre for Oncology<p> Rostov-on-Don, Russian FederationNational Medical Research Centre for Oncology<p> Rostov-on-Don, Russian FederationNational Medical Research Centre for Oncology<p> Rostov-on-Don, Russian FederationNational Medical Research Centre for Oncology<p> Rostov-on-Don, Russian FederationPurpose of the study. To determine the thyroid status of primary cancer patients in the early stages of uterine body cancer, kidney cancer, breast cancer, skin melanoma and lung cancer without a history of endocrine pathology.Patients and methods. The content levels of thyroid-stimulating hormone (TSH), thyroid hormones (THs) T4 and T3 of total and free forms were determined in the blood serum by RIA method in 132 patients with breast cancer, uterine body cancer, lung cancer, kidney cancer and skin melanoma (average age 55 years). The comparison group consisted of practically healthy donors.Results. Only in skin melanoma, serum TSH levels were reduced by 1.5 times (p < 0.05). The T4 content was reduced by 1.4–1.7 times (p < 0.05) in uterine body cancer and kidney cancer, increased in lung cancer patients and 16 % of breast cancer patients by 1.4–1.7 times though (p < 0.05). A 1.3–1.5‑fold low (p < 0.05) T3 level was found in breast cancer, kidney cancer, and skin melanoma, while an 1.6‑fold increase (p < 0.05) was found in uterine body cancer. The revealed changes in THs by the type of clinical hyperthyroidism are an increase of 1.8 times (p < 0.05) FT3 on the background of low TSH in the blood in patients with skin melanoma, and by the type of hyperthyroxinemia in patients with lung cancer and breast cancer, consisting in increased concentrations of T4 and FT3, and with free and total T3 levels in patients uterine body cancer, as well as FT4, without changes in TSH in the blood serum of patients, may be associated with the features of malignant pathology, since it is known that THs are proliferation stimulants and can build up in tumors.Conclusion. The development of a malignant tumor even in the early stages of the disease is perceived by the body as a threat for homeostasis and the response to the occurrence of neoplasm is the reaction of the hypothalamicpituitary-thyroid regulatory axis. As an outcome, patients develop euthyroid disorder syndrome.https://www.rpmj.ru/rpmj/article/view/988euthyroid disorder syndromethyroid stimulating hormonethyroid hormonescancer patients |
| spellingShingle | V. A. Bandovkina E. M. Frantsiyants A. M. Salatova M. A. Еngibaryan V. L. Volkova N. D. Cheryarina Thyroid status in patients with early stages of cancer of various localization Исследования и практика в медицине euthyroid disorder syndrome thyroid stimulating hormone thyroid hormones cancer patients |
| title | Thyroid status in patients with early stages of cancer of various localization |
| title_full | Thyroid status in patients with early stages of cancer of various localization |
| title_fullStr | Thyroid status in patients with early stages of cancer of various localization |
| title_full_unstemmed | Thyroid status in patients with early stages of cancer of various localization |
| title_short | Thyroid status in patients with early stages of cancer of various localization |
| title_sort | thyroid status in patients with early stages of cancer of various localization |
| topic | euthyroid disorder syndrome thyroid stimulating hormone thyroid hormones cancer patients |
| url | https://www.rpmj.ru/rpmj/article/view/988 |
| work_keys_str_mv | AT vabandovkina thyroidstatusinpatientswithearlystagesofcancerofvariouslocalization AT emfrantsiyants thyroidstatusinpatientswithearlystagesofcancerofvariouslocalization AT amsalatova thyroidstatusinpatientswithearlystagesofcancerofvariouslocalization AT maengibaryan thyroidstatusinpatientswithearlystagesofcancerofvariouslocalization AT vlvolkova thyroidstatusinpatientswithearlystagesofcancerofvariouslocalization AT ndcheryarina thyroidstatusinpatientswithearlystagesofcancerofvariouslocalization |